#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal squamous cell carcinoma stage III Orthostatic hypotension Leiomyosarcoma Tourette's disorder Acute promyelocytic leukaemia Immunoglobulin G4 related disease Loeys-Dietz syndrome Multifocal motor neuropathy Rhabdomyosarcoma recurrent Congenital pseudarthrosis Extranodal marginal zone B-cell lymphoma (MALT type) Lung adenocarcinoma Acute myeloid leukaemia refractory Ewing's sarcoma recurrent Atypical haemolytic uraemic syndrome More trials…

    Learn about Rare Diseases

    Alexander disease – Treatment Proteus syndrome – Diagnostics Alternating hemiplegia of childhood Burkitt’s lymphoma Aicardi-Goutieres syndrome – Treatment Mastocytosis – Diagnostics Medulloblastoma recurrent Progressive multifocal leukoencephalopathy – Treatment Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Haemophilia A without inhibitors – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elvn-002-1 Vesleteplirsen Gns561 Pasireotide Diaspartate IMB 101 ADCE-D01 Reparixin Alogliptin Iloprost Trometamol TRIMIPRAMINE MALEATE PARECOXIB Cytisine Rbd5044 Sodium LYSERGIDE 177Lu-Rhpsma-10.1 Riboflavin Sodium Phosphate REGN7544 Ibuprofen Lysine Macrogol 4000 Hydroxocobalamin More therapies…

    Learn about Your Condition

    Spondylolisthesis Tympanic membrane perforation Hepatocellular carcinoma Triple positive breast cancer Cholangiosarcoma Hepatorenal syndrome Hepatoblastoma Generalised anxiety disorder Graft versus host disease Cytomegalovirus infection Spinal muscular atrophy Cardiac arrest Psychotic disorder Periarthritis Epstein-Barr virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Octreotide in Reducing Blood Loss During Laparoscopic Liver Surgery for Patients Undergoing Hepatectomy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Octreotide
    Spain

  • Study on Desflurane, Sevoflurane, and Propofol for Postoperative Delirium in Elderly Patients Undergoing Major Abdominal Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Postoperative delirium
    Investigated Drugs:
    • Desflurane
    • Sevoflurane
    • Propofol
    Austria

  • Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    France Germany Poland Romania Spain

  • Study on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Deutivacaftor
    • Tezacaftor
    • Vanzacaftor
    Belgium France Germany The Netherlands Sweden

  • Study on the Effectiveness and Safety of Cisplatin and Paclitaxel in Advanced Ovarian Cancer Patients After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Cisplatin
    • Paclitaxel
    Spain

  • Study on Ravulizumab for Children Aged 6 to 17 with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ravulizumab
    France Italy The Netherlands Spain
Previous Page
1 … 590 591 592 593 594 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!